Update on Phase I/Ii and Phase Ii Studies of Recombinant Human N-Acetylgalactosamine 4-Sulfatase (Rhasb)) Enzyme Replacement Therapy in Patients with Mucopolysaccharidosis Vi (Maroteaux-Lamy Syndrome).
AuthID
P-000-9Q1
P-000-9Q1